170 related articles for article (PubMed ID: 35621654)
1. Invasive Fungal Disease in Patients with Chronic Lymphocytic Leukemia in Japan: A Retrospective Database Study.
Yasu T; Sakurai K; Akazawa M
Curr Oncol; 2022 May; 29(5):3242-3251. PubMed ID: 35621654
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for invasive fungal disease after allogeneic hematopoietic stem cell transplantation: a single center experience.
Omer AK; Ziakas PD; Anagnostou T; Coughlin E; Kourkoumpetis T; McAfee SL; Dey BR; Attar E; Chen YB; Spitzer TR; Mylonakis E; Ballen KK
Biol Blood Marrow Transplant; 2013 Aug; 19(8):1190-6. PubMed ID: 23747459
[TBL] [Abstract][Full Text] [Related]
3. Ibrutinib-associated invasive fungal diseases in patients with chronic lymphocytic leukaemia and non-Hodgkin lymphoma: An observational study.
Ruchlemer R; Ben-Ami R; Bar-Meir M; Brown JR; Malphettes M; Mous R; Tonino SH; Soussain C; Barzic N; Messina JA; Jain P; Cohen R; Hill B; Mulligan SP; Nijland M; Herishanu Y; Benjamini O; Tadmor T; Okamoto K; Arthurs B; Gottesman B; Kater AP; Talha M; Eichhorst B; Korem M; Bogot N; De Boer F; Rowe JM; Lachish T
Mycoses; 2019 Dec; 62(12):1140-1147. PubMed ID: 31520441
[TBL] [Abstract][Full Text] [Related]
4. Chronic lymphocytic leukemia (CLL) is rare, but the proportion of T-CLL is high in Japan.
Tamura K; Sawada H; Izumi Y; Fukuda T; Utsunomiya A; Ikeda S; Uike N; Tsukada J; Kawano F; Shibuya T; Gondo H; Okamura S; Suzumiya J;
Eur J Haematol; 2001 Sep; 67(3):152-7. PubMed ID: 11737247
[TBL] [Abstract][Full Text] [Related]
5. Real World Treatment Practices for Chronic Lymphocytic Leukemia in Japan: An Observational Database Research Study (CLIMBER-DBR).
Takizawa J; Izutsu K; Nagai H; Fukase K; Nakamura M; Jinushi M; Suzumiya J
J Clin Exp Hematop; 2021 Sep; 61(3):126-134. PubMed ID: 34092721
[TBL] [Abstract][Full Text] [Related]
6. Caspofungin Treatment for Pulmonary Invasive Fungal Disease in Hematology Patients: A Retrospective Study in a Clinical Practice Setting in China.
Zhang X; Hu J; Hu Y; Huang H; Jin J; Li J; Liu Q; Shao Z; Wang J; Wang Q; Wu D; Huang X
Clin Ther; 2017 Sep; 39(9):1758-1768. PubMed ID: 28756883
[TBL] [Abstract][Full Text] [Related]
7. Secondary antifungal prophylaxis in hematological malignancy patients with previous invasive fungal disease: a retrospective analysis.
Liu M; Li Y; Zhang Y; Zhao X; Zhai B; Zhang Q; Wang L; Zhao Y; Li H; Wang Q; Gao C; Huang W; Yu L
PLoS One; 2014; 9(12):e115461. PubMed ID: 25531544
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology, management, and outcome of invasive fungal disease in patients undergoing hematopoietic stem cell transplantation in China: a multicenter prospective observational study.
Sun Y; Meng F; Han M; Zhang X; Yu L; Huang H; Wu D; Ren H; Wang C; Shen Z; Ji Y; Huang X
Biol Blood Marrow Transplant; 2015 Jun; 21(6):1117-26. PubMed ID: 25840339
[TBL] [Abstract][Full Text] [Related]
9. A population-based analysis of attributable hospitalisation costs of invasive fungal diseases in haematological malignancy patients using data linkage of state-wide registry and costing databases: 2009-2015.
Valentine JC; Morrissey CO; Tacey MA; Liew D; Patil S; Ananda-Rajah M
Mycoses; 2020 Feb; 63(2):162-171. PubMed ID: 31715052
[TBL] [Abstract][Full Text] [Related]
10. Invasive fungal disease in patients treated for newly diagnosed acute leukemia.
Hammond SP; Marty FM; Bryar JM; DeAngelo DJ; Baden LR
Am J Hematol; 2010 Sep; 85(9):695-9. PubMed ID: 20652970
[TBL] [Abstract][Full Text] [Related]
11. Primary antifungal prophylaxis: decrease of invasive fungal disease incidence and reduction of risk factors in haematological patients in a 5-year retrospective study.
Li Y; Liu M; Zhai B; Zhao X; Wang L; Li H; Wang S; Zhu H; Wang Q; Gao C; Huang W; Yu L
Intern Med J; 2018 Jun; 48(6):713-720. PubMed ID: 29230923
[TBL] [Abstract][Full Text] [Related]
12. Breakthrough invasive fungal disease in patients receiving posaconazole primary prophylaxis: a 4-year study.
Lerolle N; Raffoux E; Socie G; Touratier S; Sauvageon H; Porcher R; Bretagne S; Bergeron A; Azoulay E; Molina JM; Lafaurie M
Clin Microbiol Infect; 2014 Nov; 20(11):O952-9. PubMed ID: 24861577
[TBL] [Abstract][Full Text] [Related]
13. Incidence and risk factors of post-engraftment invasive fungal disease in adult allogeneic hematopoietic stem cell transplant recipients receiving oral azoles prophylaxis.
Montesinos P; Rodríguez-Veiga R; Boluda B; Martínez-Cuadrón D; Cano I; Lancharro A; Sanz J; Arilla MJ; López-Chuliá F; Navarro I; Lorenzo I; Salavert M; Pemán J; Calvillo P; Martínez J; Carpio N; Jarque I; Sanz GF; Sanz MA
Bone Marrow Transplant; 2015 Nov; 50(11):1465-72. PubMed ID: 26281032
[TBL] [Abstract][Full Text] [Related]
14. A population level analysis of second hematological malignancies in chronic lymphocytic leukemia/small lymphocytic lymphoma survivors in the era of targeted therapies.
Mishra R; Dima D; Kumar SA; Mian A; Taneja A; Karna R; Caimi PF; Hill BT; Dean R; Jagadeesh D
Hematol Oncol; 2023 Dec; 41(5):884-893. PubMed ID: 37309225
[TBL] [Abstract][Full Text] [Related]
15. Primary fungal prophylaxis in acute leukemia patients with different risk factors: retrospective analysis from the CAESAR study.
Zhang R; Chen J; Huang H; Ma J; Meng F; Tang Y; Hu J; Zhang X; Ji Y; Ai H; Liang Y; Wu D; Huang X; Han M
Int J Hematol; 2017 Aug; 106(2):221-228. PubMed ID: 28390035
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for invasive fungal disease in heart transplant recipients.
Rabin AS; Givertz MM; Couper GS; Shea MM; Peixoto D; Yokoe DS; Baden LR; Marty FM; Koo S
J Heart Lung Transplant; 2015 Feb; 34(2):227-32. PubMed ID: 25455750
[TBL] [Abstract][Full Text] [Related]
17. [Epidemiology of invasive fungal disease in patients with hematological diseases].
Lin XM; Deng Q; Zhao MF; Geng L; Li YM
Zhonghua Yi Xue Za Zhi; 2013 Sep; 93(36):2876-9. PubMed ID: 24373399
[TBL] [Abstract][Full Text] [Related]
18. Clinical risk score for invasive fungal diseases in patients with hematological malignancies undergoing chemotherapy: China Assessment of Antifungal Therapy in Hematological Diseases (CAESAR) study.
Wang L; Wang Y; Hu J; Sun Y; Huang H; Chen J; Li J; Ma J; Li J; Liang Y; Wang J; Li Y; Yu K; Hu J; Jin J; Wang C; Wu D; Xiao Y; Huang X
Front Med; 2019 Jun; 13(3):365-377. PubMed ID: 30604166
[TBL] [Abstract][Full Text] [Related]
19. [Secondary antifungal prophylaxis in hematological malignancy patients with previous invasive fungal disease].
Liu MJ; Huang WR; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Apr; 23(2):596-600. PubMed ID: 25948232
[TBL] [Abstract][Full Text] [Related]
20. Indications and outcomes of antifungal therapy in French patients with haematological conditions or recipients of haematopoietic stem cell transplantation.
Herbrecht R; Caillot D; Cordonnier C; Auvrignon A; Thiébaut A; Brethon B; Michallet M; Mahlaoui N; Bertrand Y; Preziosi P; Ruiz F; Gorin NC; Gangneux JP
J Antimicrob Chemother; 2012 Nov; 67(11):2731-8. PubMed ID: 22850692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
